<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>News for Anthera Pharmaceuticals Inc - Google Finance</title>
<description>News for Anthera Pharmaceuticals Inc - Google Finance</description>
<link>http://www.google.com/finance?q=NASDAQ:ANTH&amp;amp;client=news-rss&amp;amp;ei=zdqcUdikBou_0QHJLQ</link>
<image>
<title>News for Anthera Pharmaceuticals Inc - Google Finance</title>
<url>/finance/s/M4XFgDr56u4/images/logo_us.gif</url>
<link>http://www.google.com/finance?q=NASDAQ:ANTH&amp;amp;client=news-rss&amp;amp;ei=zdqcUdikBou_0QHJLQ</link>
</image>
<item>
<title>Cytori Therapeutics Inc (NASDAQ:CYTX) up by 2.80%, Anthera Pharmaceuticals ...</title>
<link>http://gdpinsider.com/cytori-therapeutics-inc-nasdaqcytx-up-by-2-80-anthera-pharmaceuticals-inc-nasdaqanth-1700.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://gdpinsider.com/cytori-therapeutics-inc-nasdaqcytx-up-by-2-80-anthera-pharmaceuticals-inc-nasdaqanth-1700.html</guid>
<pubDate>Tue, 21 May 2013 18:25:16 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://gdpinsider.com/cytori-therapeutics-inc-nasdaqcytx-up-by-2-80-anthera-pharmaceuticals-inc-nasdaqanth-1700.html&quot; style=&quot;font-size:1.2em&quot;&gt;Cytori Therapeutics Inc (NASDAQ:CYTX) up by 2.80%, Anthera Pharmaceuticals ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;GSPInsider&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;20 hours ago &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Cytori Therapeutics Inc (NASDAQ:CYTX): In Tuesday&amp;#39;s trading session, Cytori Therapeutics Inc (NASDAQ:CYTX) jumped 2.80%.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results</title>
<link>http://www.prnewswire.com/news-releases/anthera-pharmaceuticals-reports-2013-first-quarter-financial-results-207276321.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982060523594</guid>
<pubDate>Mon, 13 May 2013 21:24:06 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.prnewswire.com/news-releases/anthera-pharmaceuticals-reports-2013-first-quarter-financial-results-207276321.html&quot; style=&quot;font-size:1.2em&quot;&gt;Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;PR Newswire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;On May 16, 2013 at 11:00 a.m. PDT, Anthera Pharmaceuticals, Inc. will hold its annual shareholder meeting at 1204 Burlingame Avenue #8, Burlingame, CA 94010.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>ANTHERA PHARMACEUTICALS INC : Anthera Announces First Quarter 2013 ...</title>
<link>http://www.4-traders.com/ANTHERA-PHARMACEUTICALS-I-5984271/news/Anthera-Pharmaceuticals-Inc-Anthera-Announces-First-Quarter-2013-Financial-Report-and-Conference-C-16810407/</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778144112902</guid>
<pubDate>Fri, 03 May 2013 18:10:28 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.4-traders.com/ANTHERA-PHARMACEUTICALS-I-5984271/news/Anthera-Pharmaceuticals-Inc-Anthera-Announces-First-Quarter-2013-Financial-Report-and-Conference-C-16810407/&quot; style=&quot;font-size:1.2em&quot;&gt;ANTHERA PHARMACEUTICALS INC : Anthera Announces First Quarter 2013 ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;4-traders (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 3, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;HAYWARD, Calif., May 3, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, will release its first quarter 2013 financial ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC ...</title>
<link>http://www.prnewswire.com/news-releases/anthera-pharmaceuticals-announces-additional-data-from-phase-2b-pearl-sc-blisibimod-study-206479951.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778147322497</guid>
<pubDate>Tue, 07 May 2013 20:32:12 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.prnewswire.com/news-releases/anthera-pharmaceuticals-announces-additional-data-from-phase-2b-pearl-sc-blisibimod-study-206479951.html&quot; style=&quot;font-size:1.2em&quot;&gt;Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;PR Newswire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 7, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;HAYWARD, Calif., May 7, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced that additional data from its ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Apricus Biosciences, Inc. (NASDAQ:APRI), Exact Sciences Corporation ...</title>
<link>http://www.sbwire.com/press-releases/apricus-biosciences-inc-nasdaqapri-exact-sciences-corporation-nasdaqexas-abraxas-petroleum-corp-nasdaqaxas-and-anthera-pharmaceuticals-inc-nasdaqanth-added-to-growing-stock-reports-nasdaq-decliners-watch-list-241150.htm</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778127312577</guid>
<pubDate>Tue, 23 Apr 2013 12:33:38 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.sbwire.com/press-releases/apricus-biosciences-inc-nasdaqapri-exact-sciences-corporation-nasdaqexas-abraxas-petroleum-corp-nasdaqaxas-and-anthera-pharmaceuticals-inc-nasdaqanth-added-to-growing-stock-reports-nasdaq-decliners-watch-list-241150.htm&quot; style=&quot;font-size:1.2em&quot;&gt;Apricus Biosciences, Inc. (NASDAQ:APRI), Exact Sciences Corporation ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;SBWire (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 23, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Apricus Biosciences, Inc. (NASDAQ:APRI), Exact Sciences Corporation (NASDAQ:EXAS), Abraxas Petroleum Corp. (NASDAQ:AXAS), and Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) Added to Growing Stock Report&amp;#39;s NASDAQ Decliners Watch List.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>HIL, OGXI, ANTH, NPTN Expected To Be Down After Next Earnings Releases</title>
<link>http://www.laserfocusworld.com/news/2013/05/02/hil-ogxi-anth-nptn-expected-to-be-down-after-next-earnings-releases.html</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778141596178</guid>
<pubDate>Thu, 02 May 2013 14:23:03 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.laserfocusworld.com/news/2013/05/02/hil-ogxi-anth-nptn-expected-to-be-down-after-next-earnings-releases.html&quot; style=&quot;font-size:1.2em&quot;&gt;HIL, OGXI, ANTH, NPTN Expected To Be Down After Next Earnings Releases&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Laser Focus world&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 2, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Hill International Inc (NYSE:HIL), OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI), Anthera Pharmaceuticals Inc (NASDAQ:ANTH), NeoPhotonics Corp (NYSE:NPTN) are all expected to be Down After their earnings are released.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Research and Markets: Systemic Lupus Erythematosus - Pipeline Review, H1 ...</title>
<link>http://online.wsj.com/article/PR-CO-20130424-905035.html?mod=googlenews_wsj</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:52778130416420</guid>
<pubDate>Wed, 24 Apr 2013 08:40:32 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://online.wsj.com/article/PR-CO-20130424-905035.html?mod=googlenews_wsj&quot; style=&quot;font-size:1.2em&quot;&gt;Research and Markets: Systemic Lupus Erythematosus - Pipeline Review, H1 ...&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Wall Street Journal (press release)&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;Apr 24, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;4SC AG -- AbGenomics International, Inc. -- Active Biotech AB -- Amgen Inc. -- Amplimmune, Inc. -- Anthera Pharmaceuticals Inc. -- Argos Therapeutics, Inc. -- Biotest AG -- Biotica Technology Ltd -- CBio Limited -- CREABILIS Therapeutics S.r.l. -- Eli ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>DIARY-NON S&amp;amp;P WEEK AHEAD</title>
<link>http://www.reuters.com/article/2013/05/10/diary-non-sp-week-idUSL3N0DR2HW20130510</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982057001602</guid>
<pubDate>Fri, 10 May 2013 10:36:44 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/10/diary-non-sp-week-idUSL3N0DR2HW20130510&quot; style=&quot;font-size:1.2em&quot;&gt;DIARY-NON S&amp;amp;P WEEK AHEAD&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 10, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... Inc N/A N/A N/A 10 May BMO Q1 2013 Vantage Drilling Co -0.06 10 0.00 13 May BMO Q1 2013 Warwick Valley Telephone Co -0.01 2 N/A 13 May AMC Q1 2013 ANTHERA PHARMACEUTICALS INC -0.09 6 -0.51 13 May AMC Q1 2013 Arotech Corp.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>Earnings Scheduled For May 13, 2013</title>
<link>http://www.benzinga.com/news/earnings/13/05/3581963/earnings-scheduled-for-may-13-2013</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:43982060521433</guid>
<pubDate>Mon, 13 May 2013 08:45:08 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.benzinga.com/news/earnings/13/05/3581963/earnings-scheduled-for-may-13-2013&quot; style=&quot;font-size:1.2em&quot;&gt;Earnings Scheduled For May 13, 2013&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Benzinga&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;Anthera Pharmaceuticals, Inc. (NASDA:ANTH) is estimated to post a Q1 loss at $0.08 per share. Augme Technologies, Inc. (NASDAQ: AUGT) is expected to post its Q4 earnings at $0.40 per share on a revenue of $8.25 million.&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
<item>
<title>US/Canada daily earnings hits &amp;amp; misses May 13 - 1800 ET</title>
<link>http://www.reuters.com/article/2013/05/13/results-surprises-idUSL3N0DU27220130513</link>
<guid isPermaLink="false">tag:finance.google.com,cluster:http://www.reuters.com/article/2013/05/13/results-surprises-idUSL3N0DU27220130513</guid>
<pubDate>Mon, 13 May 2013 12:01:20 GMT</pubDate>
<description>
&lt;div style=&quot;padding:0px; margin-bottom:1.5em;&quot;&gt;
&lt;a href=&quot;http://www.reuters.com/article/2013/05/13/results-surprises-idUSL3N0DU27220130513&quot; style=&quot;font-size:1.2em&quot;&gt;US/Canada daily earnings hits &amp;amp; misses May 13 - 1800 ET&lt;/a&gt;
&lt;br&gt; &lt;span style=&quot;color:#888888;&quot;&gt;Reuters&lt;/span&gt; - &lt;span style=&quot;white-space:nowrap&quot;&gt;May 13, 2013 &lt;/span&gt;
&lt;div style=&quot;width:80%;&quot;&gt;... 225.7 276.4 50.7 ANTHERA PHARMACEUTICALS Q1 DRUGS USD -0.09 -0.05 0.04 0.0 0.0 0.0 ARMTEC INFRASTRUCTURE INC Q1 FINANCIAL SERVICES CAD -0.31 -0.32 -0.01 85.0 78.9 -6.0 ATLAS FINANCIAL HOLDINGS Q1 FINANCIAL SERVICES ...&lt;/div&gt;
&lt;/div&gt;
</description>
</item>
</channel>
</rss>
